Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 8Gynecologic 2Sarcoma 1Plasma cell 1Other 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sexual Dysfunction, Physiological 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Exercise 27Metformin 20Surveys and Questionnaires 19Methods 14Educational Status 12Early Intervention, Educational 11Counseling 11Tirzepatide 9Standard of Care 9Nutrition Assessment 9Diet Therapy 9Resistance Training 8Radiotherapy 8Diet 8Interviews as Topic 7Liraglutide 6semaglutide 5Radiation 5Low-Level Light Therapy 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5Cryotherapy 5Caloric Restriction 5Blood Specimen Collection 5Bariatric Surgery 5Vitamin D 4Therapeutics 4Sugars 4Specimen Handling 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dehydroepiandrosterone × Other × Clear all
NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Alliance for Clinical Trials in Oncology

Phase 3 Completed
464 enrolled 8 charts
BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡